3B Future Health launches 2nd fund for U.S., European early-stage biotechs

3B Future Health launches 2nd fund for U.S., European early-stage biotechs

Source: 
Fierce Biotech
snippet: 

European life sciences VC 3B Future Health Ventures is targeting €100 million and partnering with “experienced private and institutional investors” with its second fund.